Clinical trial
Nicotinic Acid for the Treatment of Alzheimer's Disease
NCT06582706 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nicotinic Acid for the Treatment of Alzheimer's Disease
- Lead sponsor
- Indiana University
- Phase
- Phase 1/2
- Overall status
- Recruiting
- Start date
- December 19, 2024
- Completion date
- December 31, 2026
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.